New pathway discovered in cellular cholesterol regulation

May 13, 2010

Researchers at two laboratories at NYU Langone Medical Center have collaborated to identify a tiny micro-RNA, miR-33, that regulates key genes involved in cellular cholesterol transport. The study, published online May 13, 2010 in Science, found that inhibitors of miR-33 may be beneficial because they could enhance cholesterol removal from tissues and raise levels of HDL -- shown in clinical trials to promote regression of human atherosclerotic plaques. This discovery could lead to the development of new treatments for atherosclerosis that would eliminate cholesterol accumulation in the artery wall.

"High density lipoprotein (HDL), 'the good cholesterol', is thought to protect against atherosclerotic vascular disease and treatments to raise HDL are at the forefront of cardiovascular research. Our study identifies a new pathway to regulate HDL levels and suggests that antagonists of miR-33 have exciting potential for use in conjunction with traditional LDL lowering therapies to raise HDL," says Kathryn J. Moore, PhD, associate professor in the Departments of Medicine and Cell Biology at NYU Langone Medical Center and one of the senior authors of the study.

MicroRNAs have recently emerged as important regulators of genes involved in physiological pathways. This study found that inhibiting miR-33 in mice could increase HDL levels by as much as 25%, which is similar to what can be accomplished by the drug Niacin, also known as vitamin B3 or nicotinic acid.

"Our work identifies miR-33 as a key regulator of intracellular cholesterol . In , in the artery wall accumulate cholesterol, leading to . MiR-33 regulates this process by targeting pathways involved in efflux from the cell and the formation of HDL," adds co-senior author Carlos Fernandez-Hernando, PhD, assistant professor in the Departments of Medicine and Cell Biology at NYU Langone Medicine, who was recently awarded the American Heart Association's Irvine H. Page Young Investigator Award for this discovery.

This exciting collaboration between the labs of Dr.'s Moore and Fernández-Hernando emerged as a result of their participation in the Marc and Ruti Bell Vascular Biology and Disease Program, a component of the Leon H. Charney Division of Cardiology at NYU Langone Medical Center. Edward A. Fisher, PhD, MPH, MD, the Leon H. Charney Professor of Cardiovascular Medicine and professor in the Departments of Medicine, Pediatrics and Cell Biology, is the director of this program and a co-author of the study. Additional co-authors of the study include Katey Rayner, PhD, Yajaira Suárez, PhD, Alberto Dávalos, PhD and Saj Parathath PhD of NYU Langone Medical Center.

Explore further: New compounds protect nervous system from the structural damage of MS

Related Stories

Role of a key enzyme in reducing heart disease identified

Oct 24, 2007

Virginia Commonwealth University researchers have identified the role of a key enzyme called CEH in reducing heart disease, paving the way for new target therapies to reduce plaques in the arteries and perhaps ...

Recommended for you

3-D printing offers innovative method to deliver medication

30 minutes ago

3-D printing could become a powerful tool in customizing interventional radiology treatments to individual patient needs, with clinicians having the ability to construct devices to a specific size and shape. That's according ...

Mystery of the reverse-wired eyeball solved

Feb 27, 2015

From a practical standpoint, the wiring of the human eye - a product of our evolutionary baggage - doesn't make a lot of sense. In vertebrates, photoreceptors are located behind the neurons in the back of the eye - resulting ...

Neurons controlling appetite made from skin cells

Feb 27, 2015

Researchers have for the first time successfully converted adult human skin cells into neurons of the type that regulate appetite, providing a patient-specific model for studying the neurophysiology of weight ...

Quality control for adult stem cell treatment

Feb 27, 2015

A team of European researchers has devised a strategy to ensure that adult epidermal stem cells are safe before they are used as treatments for patients. The approach involves a clonal strategy where stem cells are collected ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.